Literature DB >> 7917915

Intrauterine device use and risk of endometrial cancer.

F Parazzini1, C La Vecchia, S Moroni.   

Abstract

The relationship between intrauterine device (IUD) use and risk of endometrial cancer has been analysed in a case-control study conducted in Italy between 1983 and 1992, including 453 patients with histologically confirmed endometrial cancer and 1,451 controls admitted for acute, non-gynaecological, non-hormonal, non-neoplastic conditions to the same network of hospitals where cases had been identified. Two (0.4%) cases versus 36 (2.3%) controls reported ever using an IUD. The corresponding multivariate relative risk was 0.4 (95% CI 0.1-1.0). The results of this study and the few published available epidemiological data suggest a protective role of IUD use on endometrial carcinogenesis, but potential selective mechanisms for IUD utilisation (indication bias) should be carefully considered in the interpretation.

Entities:  

Keywords:  Bias; Biology; Body Weight; Cancer; Case Control Studies; Contraception; Contraceptive Methods; Demographic Factors; Developed Countries; Diseases; Endometrial Cancer; Error Sources; Europe; Family Planning; Fertility; Fertility Measurements; Hormone Replacement Therapy; Italy; Iud; Measurement; Mediterranean Countries; Neoplasms; Nulliparity; Parity; Physiology; Population; Population Dynamics; Research Report; Southern Europe; Studies; Treatment

Mesh:

Year:  1994        PMID: 7917915      PMCID: PMC2033405          DOI: 10.1038/bjc.1994.369

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

Review 2.  The epidemiology of endometrial cancer.

Authors:  F Parazzini; C La Vecchia; L Bocciolone; S Franceschi
Journal:  Gynecol Oncol       Date:  1991-04       Impact factor: 5.482

3.  Reproductive factors and risk of endometrial cancer.

Authors:  F Parazzini; C La Vecchia; E Negri; L Fedele; F Balotta
Journal:  Am J Obstet Gynecol       Date:  1991-02       Impact factor: 8.661

Review 4.  Endometrial morphological changes in IUD users: a review.

Authors:  B L Sheppard
Journal:  Contraception       Date:  1987-07       Impact factor: 3.375

5.  Ultrastructural changes found in endometrium of women using Lippes intrauterine device.

Authors:  A González-Angulo; R Aznar-Ramos; A Feria-Velasco
Journal:  J Reprod Med       Date:  1973-02       Impact factor: 0.142

6.  Alterations in progesterone receptors in the rat uterus bearing an intra-uterine device during the oestrous cycle and early pregnancy.

Authors:  L Myatt; M G Elder; L Lim
Journal:  J Endocrinol       Date:  1980-12       Impact factor: 4.286

7.  Ultrastructural changes in human endometrium with copper and nonmedicated IUDs in utero.

Authors:  H H El-Badrawi; E S Hafez; M I Barnhart; M Fayad; A Shafeek
Journal:  Fertil Steril       Date:  1981-07       Impact factor: 7.329

8.  Intra-uterine contraception and the risk of endometrial cancer.

Authors:  X Castellsagué; W D Thompson; R Dubrow
Journal:  Int J Cancer       Date:  1993-07-30       Impact factor: 7.396

9.  The mechanism of action of the copper intrauterine device.

Authors:  T Tamaya; Y Nakata; Y Ohno; S Nioka; N Furuta
Journal:  Fertil Steril       Date:  1976-07       Impact factor: 7.329

  9 in total
  2 in total

1.  Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006.

Authors:  Tsogzolmaa Dorjgochoo; Xiao-Ou Shu; Hong-Lan Li; Han-Zhu Qian; Gong Yang; Hui Cai; Yu-Tang Gao; Wei Zheng
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

2.  Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.

Authors:  Ashley S Felix; Mia M Gaudet; Carlo La Vecchia; Christina M Nagle; Xiao Ou Shu; Elisabete Weiderpass; Hans Olov Adami; Shirley Beresford; Leslie Bernstein; Chu Chen; Linda S Cook; Immaculata De Vivo; Jennifer A Doherty; Christine M Friedenreich; Susan M Gapstur; Dierdre Hill; Pamela L Horn-Ross; James V Lacey; Fabio Levi; Xiaolin Liang; Lingeng Lu; Anthony Magliocco; Susan E McCann; Eva Negri; Sara H Olson; Julie R Palmer; Alpa V Patel; Stacey Petruzella; Jennifer Prescott; Harvey A Risch; Lynn Rosenberg; Mark E Sherman; Amanda B Spurdle; Penelope M Webb; Lauren A Wise; Yong-Bing Xiang; Wanghong Xu; Hannah P Yang; Herbert Yu; Anne Zeleniuch-Jacquotte; Louise A Brinton
Journal:  Int J Cancer       Date:  2014-09-30       Impact factor: 7.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.